Epithelial ovarian cancer risk: A review of the current genetic landscape
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Epithelial ovarian cancer risk: A review of the current genetic landscape
Authors
Keywords
-
Journal
CLINICAL GENETICS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-05-17
DOI
10.1111/cge.13566
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Population-based testing of non-mucinous epithelial ovarian cancer in Scotland
- (2018) DG Evans et al. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
- The uptake of presymptomatic genetic testing in hereditary breast-ovarian cancer and Lynch syndrome: a systematic review of the literature and implications for clinical practice
- (2018) Fred H Menko et al. Familial Cancer
- Risk, Prediction and Prevention of Hereditary Breast Cancer – Large-Scale Genomic Studies in Times of Big and Smart Data
- (2018) Marius Wunderle et al. GEBURTSHILFE UND FRAUENHEILKUNDE
- Landscape of pathogenic variations in a panel of 34 genes and cancer risk estimation from 5131 HBOC families
- (2018) Laurent Castéra et al. GENETICS IN MEDICINE
- Mismatch repair deficiency is associated with MSI phenotype, increased tumor-infiltrating lymphocytes and PD-L1 expression in immune cells in ovarian cancer
- (2018) Xue Xiao et al. GYNECOLOGIC ONCOLOGY
- Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population Women
- (2018) Ranjit Manchanda et al. JNCI-Journal of the National Cancer Institute
- Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population Women
- (2018) Ranjit Manchanda et al. JNCI-Journal of the National Cancer Institute
- A Dominantly Inherited 5′ UTR Variant Causing Methylation-Associated Silencing of BRCA1 as a Cause of Breast and Ovarian Cancer
- (2018) D.Gareth R. Evans et al. AMERICAN JOURNAL OF HUMAN GENETICS
- A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk
- (2018) Yingchang Lu et al. CANCER RESEARCH
- Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
- (2018) Kathleen Moore et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ovarian cancer
- (2017) Carlo La Vecchia EUROPEAN JOURNAL OF CANCER PREVENTION
- Cancer risk and survival inpath_MMRcarriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database
- (2017) Pål Møller et al. GUT
- Pathological features and clinical behavior of Lynch syndrome-associated ovarian cancer
- (2017) N.A.J. Ryan et al. GYNECOLOGIC ONCOLOGY
- Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening Study
- (2017) Adam N. Rosenthal et al. JOURNAL OF CLINICAL ONCOLOGY
- Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Robert L Coleman et al. LANCET
- Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer
- (2017) Catherine M Phelan et al. NATURE GENETICS
- A mutational signature reveals alterations underlying deficient homologous recombination repair in breast cancer
- (2017) Paz Polak et al. NATURE GENETICS
- Association of Mismatch Repair Mutation With Age at Cancer Onset in Lynch Syndrome
- (2017) Neil A. J. Ryan et al. JAMA Oncology
- Epidemiology of ovarian cancer: a review
- (2017) Reid Brett M. et al. Cancer Biology & Medicine
- Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1)
- (2017) Philipp Harter et al. PLoS One
- BRCA somatic mutations and epigenetic BRCA modifications in serous ovarian cancer
- (2016) M. Moschetta et al. ANNALS OF ONCOLOGY
- Mucinous ovarian cancer: A therapeutic review
- (2016) Wen Xu et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- RNF138 interacts with RAD51D and is required for DNA interstrand crosslink repair and maintaining chromosome integrity
- (2016) Brian D. Yard et al. DNA REPAIR
- Bilateral salpingectomy can reduce the risk of ovarian cancer in the general population: A meta-analysis
- (2016) Sang-Hee Yoon et al. EUROPEAN JOURNAL OF CANCER
- Low-grade serous ovarian cancer: A review
- (2016) Anis Kaldawy et al. GYNECOLOGIC ONCOLOGY
- Inherited Mutations in Women With Ovarian Carcinoma
- (2016) Barbara M. Norquist et al. JAMA Oncology
- HBOC multi-gene panel testing: comparison of two sequencing centers
- (2015) Christopher Schroeder et al. BREAST CANCER RESEARCH AND TREATMENT
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer
- (2015) Joan L. Walker et al. CANCER
- Common variants at theCHEK2gene locus and risk of epithelial ovarian cancer
- (2015) Kate Lawrenson et al. CARCINOGENESIS
- Serous ovarian, fallopian tube and primary peritoneal cancers: A common disease or separate entities — A systematic review
- (2015) Rie D. Sørensen et al. GYNECOLOGIC ONCOLOGY
- Two decades beyond BRCA1/2: Homologous recombination, hereditary cancer risk and a target for ovarian cancer therapy
- (2015) Christine S. Walsh GYNECOLOGIC ONCOLOGY
- Hereditary predisposition to ovarian cancer, looking beyond BRCA1/BRCA2
- (2015) Lindsey E. Minion et al. GYNECOLOGIC ONCOLOGY
- Pathology of cancers of the female genital tract
- (2015) Jaime Prat INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
- Impact of Age and Primary Disease Site on Outcome in Women With Low-Grade Serous Carcinoma of the Ovary or Peritoneum: Results of a Large Single-Institution Registry of a Rare Tumor
- (2015) David M. Gershenson et al. JOURNAL OF CLINICAL ONCOLOGY
- Contribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the Population
- (2015) Honglin Song et al. JOURNAL OF CLINICAL ONCOLOGY
- Olaparib Monotherapy in Patients With Advanced Cancer and a GermlineBRCA1/2Mutation
- (2015) Bella Kaufman et al. JOURNAL OF CLINICAL ONCOLOGY
- Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer
- (2015) Susan J. Ramus et al. JNCI-Journal of the National Cancer Institute
- Breast Cancer Risk After Salpingo-Oophorectomy in Healthy BRCA1/2 Mutation Carriers: Revisiting the Evidence for Risk Reduction
- (2015) B. A. M. Heemskerk-Gerritsen et al. JNCI-Journal of the National Cancer Institute
- Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants
- (2015) Nasim Mavaddat et al. JNCI-Journal of the National Cancer Institute
- Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies
- (2015) LANCET
- Referral of Ovarian Cancer Patients for Genetic Counselling by Oncologists: Need for Improvement
- (2015) Maria Teresa Ricci et al. Public Health Genomics
- Hereditary Ovarian Cancer: Not OnlyBRCA1 and 2 Genes
- (2015) Angela Toss et al. Biomed Research International
- Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer
- (2015) Susan J. Ramus et al. JNCI-Journal of the National Cancer Institute
- Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants
- (2015) Nasim Mavaddat et al. JNCI-Journal of the National Cancer Institute
- Breast Cancer Risk After Salpingo-Oophorectomy in Healthy BRCA1/2 Mutation Carriers: Revisiting the Evidence for Risk Reduction
- (2015) B. A. M. Heemskerk-Gerritsen et al. JNCI-Journal of the National Cancer Institute
- Adherence to Mediterranean diet and risk of cancer: an updated systematic review and meta-analysis of observational studies
- (2015) Lukas Schwingshackl et al. Cancer Medicine
- RAD51C germline mutations found in Spanish site-specific breast cancer and breast-ovarian cancer families
- (2014) Ana Blanco et al. BREAST CANCER RESEARCH AND TREATMENT
- Effects of BRCA1- and BRCA2-Related Mutations on Ovarian and Breast Cancer Survival: A Meta-analysis
- (2014) Q. Zhong et al. CLINICAL CANCER RESEARCH
- The breast cancer susceptibility genes (BRCA) in breast and ovarian cancers
- (2014) Arindam Paul Frontiers in Bioscience-Landmark
- The contribution of deleterious germline mutations in BRCA1, BRCA2 and the mismatch repair genes to ovarian cancer in the population
- (2014) H. Song et al. HUMAN MOLECULAR GENETICS
- Ovarian cancer
- (2014) Gordon C Jayson et al. LANCET
- Dietary Intake and Ovarian Cancer Risk: A Systematic Review
- (2013) T. E. Crane et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Germline and Somatic Mutations in Homologous Recombination Genes Predict Platinum Response and Survival in Ovarian, Fallopian Tube, and Peritoneal Carcinomas
- (2013) Kathryn P. Pennington et al. CLINICAL CANCER RESEARCH
- Cascade carrier testing after a child is diagnosed with cystic fibrosis through newborn screening: investigating why most relatives do not have testing
- (2013) Belinda J. McClaren et al. GENETICS IN MEDICINE
- Mismatch repair deficiency in ovarian cancer — Molecular characteristics and clinical implications
- (2013) Xue Xiao et al. GYNECOLOGIC ONCOLOGY
- Reproductive factors for ovarian cancer in southern Chinese women
- (2013) Maria Pasalich et al. Journal of Gynecologic Oncology
- Ovarian cancer familial relative risks by tumour subtypes and by known ovarian cancer genetic susceptibility variants
- (2013) Sarah Jervis et al. JOURNAL OF MEDICAL GENETICS
- The Changing View of High-Grade Serous Ovarian Cancer
- (2012) E. M. J. J. Berns et al. CANCER RESEARCH
- Clinicopathological Features of Homologous Recombination-Deficient Epithelial Ovarian Cancers: Sensitivity to PARP Inhibitors, Platinum, and Survival
- (2012) A. Mukhopadhyay et al. CANCER RESEARCH
- Alcohol drinking and epithelial ovarian cancer risk. A systematic review and meta-analysis
- (2012) Matteo Rota et al. GYNECOLOGIC ONCOLOGY
- Hereditary gynaecological malignancies: advances in screening and treatment
- (2012) Ann K Folkins et al. HISTOPATHOLOGY
- BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group
- (2012) Kathryn Alsop et al. JOURNAL OF CLINICAL ONCOLOGY
- Ovarian cancer and smoking: individual participant meta-analysis including 28 114 women with ovarian cancer from 51 epidemiological studies
- (2012) LANCET ONCOLOGY
- Germline RAD51C mutations confer susceptibility to ovarian cancer
- (2012) Chey Loveday et al. NATURE GENETICS
- Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
- (2012) Jonathan Ledermann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Homologous recombination and its regulation
- (2012) L. Krejci et al. NUCLEIC ACIDS RESEARCH
- Ovarian Cancer and Body Size: Individual Participant Meta-Analysis Including 25,157 Women with Ovarian Cancer from 47 Epidemiological Studies
- (2012) PLOS MEDICINE
- Cancer predisposing BARD1 mutations in breast–ovarian cancer families
- (2011) Magdalena Ratajska et al. BREAST CANCER RESEARCH AND TREATMENT
- Contribution of Inherited Mutations in the BRCA2-Interacting Protein PALB2 to Familial Breast Cancer
- (2011) S. Casadei et al. CANCER RESEARCH
- Cancer Risks Associated With Germline Mutations in MLH1, MSH2, and MSH6 Genes in Lynch Syndrome
- (2011) Valérie Bonadona JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Phase II, Open-Label, Randomized, Multicenter Study Comparing the Efficacy and Safety of Olaparib, a Poly (ADP-Ribose) Polymerase Inhibitor, and Pegylated Liposomal Doxorubicin in Patients WithBRCA1orBRCA2Mutations and Recurrent Ovarian Cancer
- (2011) Stan B. Kaye et al. JOURNAL OF CLINICAL ONCOLOGY
- Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study
- (2011) Karen A Gelmon et al. LANCET ONCOLOGY
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Germline mutations in RAD51D confer susceptibility to ovarian cancer
- (2011) Chey Loveday et al. NATURE GENETICS
- Mutations in BRIP1 confer high risk of ovarian cancer
- (2011) Thorunn Rafnar et al. NATURE GENETICS
- Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing
- (2011) T. Walsh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tubal ligation and the risk of ovarian cancer: review and meta-analysis
- (2010) D. Cibula et al. HUMAN REPRODUCTION UPDATE
- Poly(ADP)-Ribose Polymerase Inhibition: Frequent Durable Responses inBRCACarrier Ovarian Cancer Correlating With Platinum-Free Interval
- (2010) Peter C. Fong et al. JOURNAL OF CLINICAL ONCOLOGY
- Therapeutic Potential of Poly(ADP-ribose) Polymerase Inhibitor AG014699 in Human Cancers With Mutated or Methylated BRCA1 or BRCA2
- (2010) Yvette Drew et al. JNCI-Journal of the National Cancer Institute
- Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
- (2010) Andrew Tutt et al. LANCET
- Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
- (2010) M William Audeh et al. LANCET
- Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene
- (2010) Alfons Meindl et al. NATURE GENETICS
- Survival in women with MMR mutations and ovarian cancer: a multicentre study in Lynch syndrome kindreds
- (2009) E. M. Grindedal et al. JOURNAL OF MEDICAL GENETICS
- Meta-analysis of Risk Reduction Estimates Associated With Risk-Reducing Salpingo-oophorectomy in BRCA1 or BRCA2 Mutation Carriers
- (2009) T. R. Rebbeck et al. JNCI-Journal of the National Cancer Institute
- Hereditary ovarian carcinoma: Heterogeneity, molecular genetics, pathology, and management
- (2009) Henry T. Lynch et al. Molecular Oncology
- Inhibition of Poly(ADP-Ribose) Polymerase in Tumors fromBRCAMutation Carriers
- (2009) Peter C. Fong et al. NEW ENGLAND JOURNAL OF MEDICINE
- TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical Use
- (2009) M. Olivier et al. Cold Spring Harbor Perspectives in Biology
- Endometrioid epithelial ovarian cancer
- (2008) Dawn J. Storey et al. CANCER
- A review of the clinical relevance of mismatch-repair deficiency in ovarian cancer
- (2008) Tuya Pal et al. CANCER
- Risk of epithelial ovarian cancer in relation to benign ovarian conditions and ovarian surgery
- (2008) Mary Anne Rossing et al. CANCER CAUSES & CONTROL
- Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers
- (2008) John K. Chan et al. GYNECOLOGIC ONCOLOGY
- “BRCAness” Syndrome in Ovarian Cancer: A Case-Control Study Describing the Clinical Features and Outcome of Patients With Epithelial Ovarian Cancer Associated WithBRCA1andBRCA2Mutations
- (2008) David S.P. Tan et al. JOURNAL OF CLINICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now